GAITHERSBURG, Md. -- - Avandia should be pulled from the market, a high-profile drug safety reviewer from the Food and Drug Administration testified today.
Dr. David Graham, who has been a critic of his own agency's handling of drug safety imbroglios in the past, believes the controversial diabetes pill should be removed from the market, in a presentation this morning before expert panels advising the FDA.
"(Avandia) increases the risk of cardiovascular risk compared to its non-use," he said. "A wrong decision will cost thousands of lives."
In his testimony, Graham said 70 percent of all diabetes patients eventually die of heart disease so any drug that raises that risk is "unacceptable."
What GSK Say - HERE
Author of The evidence, however, is clear, the Seroxat scandal
Citizens Commission on Human Rights Award Recipient (Twice)